Disorder within order: Identification of the disordered loop of STAS domain as the inhibitory domain in SLC26A9 chloride channel
- PMID: 39732169
- PMCID: PMC11834044
- DOI: 10.1016/j.jbc.2024.108145
Disorder within order: Identification of the disordered loop of STAS domain as the inhibitory domain in SLC26A9 chloride channel
Abstract
The chloride transporter-channel SLC26A9 is mediated by a reciprocal regulatory mechanism through the interaction between its cytoplasmic sulfate transporter and anti-sigma (STAS) domain and the R domain of cystic fibrosis (CF) transmembrane regulator. In vertebrate Slc26a9s, the STAS domain structures are interrupted by a disordered loop which is conserved in mammals but is variable in nonmammals. Despite the numerous studies involving the STAS domains in SLC26 proteins, the role of the disordered loop region has not been identified. Deletion of the entire Slc26a9-STAS domain results in loss of Cl- channel function. Surprisingly, we found that partial or full deletion of the STAS-disordered loop substantially increases the SLC26A9 chloride transport-channel activity. Bioinformatics analysis reveals that the disordered loops there are three subregions: a K/R-rich region, a "middle" region, and an ordered S/T-rich motif. In this study, the role of this STAS-disordered loop is investigated by using serial deletions and the ordered S/T-rich motif is examined by serial alanine substitution. Substitutions of alanine for serine or threonine in the 620 to 628 S/T-rich motif decrease SLC26A9 chloride channel activity. These experiments parse the functional roles of SLC26A9-STAS-disordered loop and its subdivisions modifying overall SLC26A9 activities. Recently, SLC26A9 has emerged as one of the potential substitutes for abnormal CF transmembrane regulator in CF. Our findings suggest that deletion of variable loop of human SLC26A9 may provide a new gene therapy strategy in the treatment of CF disease.
Keywords: SLC26A9 chloride channel; STAS domain; disordered loop; function control; inhibitory domain.
Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article.
Figures










Similar articles
-
Slc26a9 is inhibited by the R-region of the cystic fibrosis transmembrane conductance regulator via the STAS domain.J Biol Chem. 2009 Oct 9;284(41):28306-28318. doi: 10.1074/jbc.M109.001669. Epub 2009 Jul 30. J Biol Chem. 2009. PMID: 19643730 Free PMC article.
-
The role of the STAS domain in SLC26A9 for chloride ion transporter function.Biophys J. 2024 Jun 18;123(12):1751-1762. doi: 10.1016/j.bpj.2024.05.018. Epub 2024 May 21. Biophys J. 2024. PMID: 38773769 Free PMC article.
-
The anion transporter SLC26A9 localizes to tight junctions and is degraded by the proteasome when co-expressed with F508del-CFTR.J Biol Chem. 2019 Nov 29;294(48):18269-18284. doi: 10.1074/jbc.RA119.010192. Epub 2019 Oct 23. J Biol Chem. 2019. PMID: 31645438 Free PMC article.
-
SLC26A9 as a Potential Modifier and Therapeutic Target in Cystic Fibrosis Lung Disease.Biomolecules. 2022 Jan 25;12(2):202. doi: 10.3390/biom12020202. Biomolecules. 2022. PMID: 35204703 Free PMC article. Review.
-
Functional interaction of the cystic fibrosis transmembrane conductance regulator with members of the SLC26 family of anion transporters (SLC26A8 and SLC26A9): physiological and pathophysiological relevance.Int J Biochem Cell Biol. 2014 Jul;52:58-67. doi: 10.1016/j.biocel.2014.02.001. Epub 2014 Feb 14. Int J Biochem Cell Biol. 2014. PMID: 24530837 Review.
Cited by
-
Ex vivo quantification of intracellular pH in Drosophila Malpighian tubule reveals basolateral HCO3 -/oxalate exchange through a novel oxalate transporter "Neat".Front Physiol. 2025 Apr 28;16:1468451. doi: 10.3389/fphys.2025.1468451. eCollection 2025. Front Physiol. 2025. PMID: 40356774 Free PMC article.
References
-
- Lu F., Li S., Jiang Y., Jiang J., Fan H., Lu G., et al. Structure and mechanism of the uracil transporter UraA. Nature. 2011;472:243–246. - PubMed
-
- Arakawa T., Kobayashi-Yurugi T., Alguel Y., Iwanari H., Hatae H., Iwata M., et al. Crystal structure of the anion exchanger domain of human erythrocyte band 3. Science. 2015;350:680–684. - PubMed
-
- Geertsma E.R., Chang Y.-N., Shaik F.R., Neldner Y., Pardon E., Steyaert J., et al. Structure of a prokaryotic fumarate transporter reveals the architecture of the SLC26 family. Nat. Struct. Mol. Biol. 2015;22:803–808. - PubMed
-
- Aravind L., Koonin E.V. The STAS domain - a link between anion transporters and antisigma-factor antagonists. Curr. Biol. 2000;10:R53–R55. - PubMed
-
- Songyang Z., Fanning A.S., Fu C., Xu J., Marfatia S.M., Chishti A.H., et al. Recognition of unique carboxyl-terminal motifs by distinct PDZ domains. Science. 1997;275:73–77. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources